1. |
Schainfeld RM, Isner JM. Critical limb ischemia:nothing to give at the office?[J]. Ann Intern Med, 1999, 130(5):442-444.
|
2. |
van Royen N, Hoefer I, Bottinger M, et al. Local monocytechemoattractant protein-1 therapy increases collateral artery formationin apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression[J]. Circ Res, 2003, 92(2):218-225.
|
3. |
Takeshita S, Tsurumi Y, Couffinahl T, et al. Gene transfer of naked DNA encoding for three isoforms of vascular, endothelial growth factor stimulates collateral development in vivo[J]. Lab Invest, 1996, 75(4):487-501.
|
4. |
Taniyama Y, Morishita R, Aoki M, et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models:preclinical study for treatment of peripheral arterial disease[J]. Gene Ther, 2001, 8(3):181-189.
|
5. |
Paek R, Chang DS, Brevetti LS, et al. Correlation of a simple direct measurement of muscle pO2 to a clinical ischemia index and histology in a rat model of chronic severe hindlimb ischemia[J] . J Vasc Surg , 2002, 36(1):172-179.
|
6. |
Shyu KG, Manor O, Magner M, et al. Direct intramuscularinjection of plasmid DNA encoding angiopoietin-1 but notangiopoietin-2 augments revascularization in the rabbit ischemic hindlimb[J]. Circulation, 1998, 98(19):2081-2087.
|
7. |
Chang DS, Su H, Tang GL, et al. Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscleoxygen tension and induces arteriogenesis in ischemic rat hindlimb[J]. Mol Ther, 2003, 7(1):44-51.
|
8. |
Brevetti LS, Chang DS, Tang GL, et al. Overexpression of endothelial nitric oxide synthase increases skeletal muscle blood flow and oxygenation in severe rat hindlimb ischemia[J]. J Vasc Surg, 2003, 38(4):820-826.
|
9. |
Lederman RJ, Mendelsohn FO, Anderson RD,?et al. Therapeuticangiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study):a randomised trial[J]. Lancet, 2002, 359(9323):2053-2058.
|
10. |
Aviles RJ, Annex BH, Lederman RJ, et al. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2)[J]. Br J Pharmacol, 2003, 140(4):637-646.
|
11. |
Rajagopalan S, Mohler ER 3rd, Lederman RJ, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease:a phaseⅡrandomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor121 in patients with disabling intermittent claudication[J].Circulation, 2003, 108(16):1933-1938.
|
12. |
Pu LQ, Jackson S, Lachapelle KJ, et al. A persistent hindlimb ischemia model in the rabbit[J]. J Invest Surg, 1994, 7(1):49-60.
|
13. |
Couffinhal T, Silver M, Zheng LP, et al . Mouse model ofangiogenesis[J]. Am J Pathol, 1998, 152(6):1667-1679.
|
14. |
Ito WD, Arras M, Scholz D, et al. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion[J]. Am J Physiol , 1997, 273(3 Pt 2):H1255-H1265.
|
15. |
杨盛家, 陈兵, 罗涛, 等. 大鼠后肢急性缺血模型的构建与评估[J]. 中国普通外科杂志, 2009, 18(6):580-583.
|
16. |
梁翠宏, 田铧, 徐蕴, 等. 结扎切断法与白芨微粒栓塞法建立大鼠后肢缺血模型效果比较[J]. 山东大学学报, 2007, 45(10):1008-1015.
|
17. |
Tang GL, Chang DS, Sarkar R, et al. The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia[J] . J Vasc Surg, 2005, 41(2):312-320.
|
18. |
Baffour R, Garb JL, Kaufman J, et al. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model[J] . J Surg Res, 2000, 93(2):219-229.
|
19. |
刘坤, 杨琨, 罗军, 等. 结扎腹主动脉加双侧腹壁阴部动脉在大鼠后肢缺血模型中的应用[J]. 中国普外基础与临床杂志, 2010, 17(3):258-262.
|
20. |
杨盛家, 陈兵, 佟铸, 等. 应用激光多普勒血流仪对大鼠后肢缺血模型血流动力学的观察[J]. 中国普外基础与临床杂志, 2010, 17(3):137-140.
|
21. |
Topper JN, Gimbrone MA Jr. Blood flow and vascular gene expression:fluid shear stress as a modulator of endothelial phenotype[J] . Mol Med Today, 1999, 5(1):40-46.
|
22. |
Garcia-Cardena G, Comander J, Anderson KR, et al. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype[J] . Proc Natl Acad Sci U S A, 2001, 98(8):4478-4485.
|
23. |
Buschmann IR, Hoefer IE, van Royen N, et al. GM-CSF:a strong arteriogenic factor acting by amplification of monocyte function[J] . Atherosclerosis, 2001, 159(2):343-356.
|
24. |
van Royen N, Hoefer I, Buschmann I, et al. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits[J]. Cardiovasc Res, 2003, 57(1):178-185.
|